TrialJournal of cancer research and clinical oncology2011

Serum TNF-α, B2M and sIL-2R levels are biological correlates of outcome in adjuvant IFN-α2b treatment of patients with melanoma.

Maja A Hofmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.